Vice President of Clinical Development

Summary

Join Recursion Pharmaceuticals as their Vice President of Clinical Development, Rare Disease. In this leadership role, you will champion advanced computational approaches in clinical development, defining and executing strategies for the rare disease portfolio. You will be responsible for clinical trial design and execution, medical governance, and ensuring ethical conduct of studies. The position requires strong collaboration with internal and external stakeholders, including data science teams, to integrate AI/ML tools and real-world evidence into clinical decision-making. Success in this role demands a deep understanding of rare diseases, clinical development fundamentals, and the ability to navigate the unique challenges of this space. This is a hybrid position based in New York City.

Requirements

• Prior experience in the rare disease space with an understanding of the unique clinical and regulatory challenges is important
• MD required, with 7+ years’ experience in Clinical Development in a Pharmaceutical or Biotechnology company
• Experience in design, execution, and monitoring of clinical trials in rare diseases is required
• Understands the entirety of R&D across the development/commercial life cycle to allow impact across all functions: discovery, late-stage development, regulatory, manufacturing, and commercial
• Capable of prioritizing tasks and delivering on deadlines with attention to detail
• Demonstrated experience integrating AI/ML technologies into clinical development strategies
• Effective skills directed toward driving collaboration, achieving results, influencing, and resolving conflicts across internal and external stakeholders
• Highly motivated, decisive, and results-oriented individual who is proactive, resourceful, and efficient with the flexibility and creativity to excel in and contribute to a rapidly growing drug discovery and development company

Responsibilities

• Provide significant input on clinical plans, trial design, clinical trial execution, medical governance, at a program level, and ensure appropriate and adequate clinical resourcing
• Define disease area strategies and priorities, ensure patient focus and robust evidence package to support successful filings, approvals and commercialization and patient access
• Accountable for the ethical conduct of studies in the rare disease portfolio
• Operate as a single point of accountability for medical governance at the clinical level
• Ensure adequate clinical oversight of clinical research initiatives and provide a global and objective viewpoint of safety and efficacy by cultivating and sustaining a culture of openness and transparency with patient wellbeing as the key driver in decision-making
• Evaluate , integrate, and scale AI/ML tools to optimize trial design, enhance patient recruitment strategies, and drive real-time data analysis
• Foster a deep partnership with data science teams to seamlessly embed real-world evidence, big data, and advanced analytics into clinical decision-making, ensuring smarter, faster, and more adaptive clinical development
• Responsible for drafting and reviewing medical aspects of core study and regulatory documents (i.e., protocols, investigator brochures, INDs, briefing documents, etc.)
• Manage and maintain strong, effective relationships with key external stakeholders and partners (i.e., Key Opinion Leaders and investigators, consultants, patient advocacy groups and other external clinical trial participants) to ensure that the primary goals of the clinical development programs are met
• Responsible for exploring opportunities for simplification, ensuring that this area is as effective and as efficient as possible to get drugs to patients faster

Preferred Qualifications

• The ideal candidate will also need to have a keen interest and experience in working with discovery colleagues towards advancing molecules to IND
• You will need a unique combination of strong fundamentals in clinical development and the ability to be creative in identifying and crafting the right strategy for diseases with very little precedent

Benefits

• Bonuses and equity compensation
• Comprehensive benefits package